POSSIBLE STRATEGIES TO OVERCOME DRUG RESISTANCE IN BIOFILM
Joint Event on 2nd World Congress on CARDIOLOGY & 39th Annual Congress on MICROBIOLOGY AND MICROBIAL INFECTION
July 23-24, 2018 | Rome , Italy
Claudia Vuotto and Gianfranco Donelli
Fondazione Santa Lucia IRCCS, Microbial Biofilm Laboratory, Italy
Scientific Tracks Abstracts : Biomed Res
DOI: 10.4066/biomedicalresearch-C1-002
Abstract:
Biofilm-growing nosocomial pathogens represent a serious public health concern. In fact, the biofilm mode of growth is highly relevant in clinical settings where these microbial communities, displaying higher levels of antimicrobial resistance, cause several difficult-to-treat chronic infections. The reduced effectiveness of many antibiotics against bacteria grown as biofilm is due to the presence of the exopolysaccharide matrix, the reduced growth rate of microbial cells and the significant increase in the level of horizontal gene transfer. The relapsing nature of biofilm-related infections makes increasingly necessary to discover new antimicrobial agents able to interfere with biofilm formation and maturation, without inducing antibiotic resistance. This presentation will focus on biofilm resistance in aerobic and anaerobic species, underlining their response to antibiotics in terms of matrix production and induction of a viable but non-culturable state. Refractory medical devices and not-inducing resistance, antibacterial compounds will be presented as possible anti-biofilm strategies.
Biography:
Claudia Vuotto is currently working in the Microbial Bioflim Laboratory and she is also an associate with Fondazione Santa Lucia IRCCS.
E-mail: c.vuotto@hsantalucia.it
PDF HTML